Literature DB >> 34631296

Mid-Carpal Joint Sparing Procedure for Idiopathic Avascular Necrosis of Capitate.

Mohammed Tahir Ansari1, Ritvik Janardhanan1.   

Abstract

Background  Avascular necrosis of the capitate (AVNC) is an uncommon pathology of the wrist. Several procedures have been described for the treatment of AVNC. The type of treatment varies depending upon the stages. In early stages, revascularization procedures are performed. If secondary osteoarthritis develops, then the treatment options include intercarpal fusion, four corner fusion, prosthesis replacement of the capitate, tendon interposition, and wrist arthrodesis. No long-term study is available for choosing an appropriate method of the treatment for AVNC. Case Description  Herein, we report a case of AVNC that was managed by hemi-resection of the capitate with capito-hamate fusion and tendon interposition. One year after surgery, patient was asymptomatic and radiographs revealed fusion of capito-hamate joint and maintenance of the mid-carpal joint space. There was no evidence of carpal collapse. Literature Review  All the literature about mid-carpal joint sparing (MCJS) procedures has been reviewed in this report. This is a goal behind writing of this case report as there have been very few publications about these procedures. Clinical Relevance  This case illustrates the successful treatment of AVNC by MCJS procedure. The intercarpal fusion and the four corner fusion are one time procedures, and these can be used if the MCJS procedure fails or sometimes, as primary procedure, if the patient gives consent for the same. It appears prudent to save arthrodesis procedures for the future. Thieme. All rights reserved.

Entities:  

Keywords:  avascular necrosis; capitates; fusion; mid-carpal joint

Year:  2020        PMID: 34631296      PMCID: PMC8489999          DOI: 10.1055/s-0040-1718907

Source DB:  PubMed          Journal:  J Wrist Surg        ISSN: 2163-3916


  10 in total

Review 1.  Avascular necrosis of the capitate: a case report.

Authors:  A S Lapinsky; G R Mack
Journal:  J Hand Surg Am       Date:  1992-11       Impact factor: 2.230

Review 2.  [Avascular necrosis of the capitate: a case report and a review of the literature].

Authors:  G Dereudre; A Kaba; E Pansard; H Mathevon; O Mares
Journal:  Chir Main       Date:  2010-04-22

3.  Vascularized pedicled bone graft for avascular necrosis of the capitate: case report.

Authors:  Yasunori Hattori; Kazuteru Doi; Soutetsu Sakamoto; Kiminori Yukata; Mohamed Shafi; Kamil Akhundov
Journal:  J Hand Surg Am       Date:  2009-06-04       Impact factor: 2.230

4.  [Therapy of capitate bone necrosis by partial alloplastic replacement].

Authors:  D Gadzaly
Journal:  Z Orthop Ihre Grenzgeb       Date:  1983 May-Jun

5.  Surgical treatment of avascular necrosis of the proximal pole of the capitate--Case report.

Authors:  R B Kimmel; E T O'Brien
Journal:  J Hand Surg Am       Date:  1982-05       Impact factor: 2.230

6.  Postsurgical rehabilitative management of avascular necrosis in the capitate.

Authors:  David P DeSantis
Journal:  J Manipulative Physiol Ther       Date:  2004-10       Impact factor: 1.437

7.  Intraosseous blood supply of the capitate and its correlation with aseptic necrosis.

Authors:  R Vander Grend; P C Dell; F Glowczewskie; B Leslie; L K Ruby
Journal:  J Hand Surg Am       Date:  1984-09       Impact factor: 2.230

8.  Arthroscopic Partial Capitate Resection for Type Ia Avascular Necrosis: A Short-Term Outcome Analysis.

Authors:  Takamasa Shimizu; Shohei Omokawa; Francisco del Piñal; Koji Shigematsu; Hisao Moritomo; Yasuhito Tanaka
Journal:  J Hand Surg Am       Date:  2015-12       Impact factor: 2.230

Review 9.  Avascular necrosis of the capitate: report of six cases and review of the literature.

Authors:  S J Peters; I Degreef; L De Smet
Journal:  J Hand Surg Eur Vol       Date:  2014-02-25

Review 10.  [Idiopathic aseptic osteonecrosis of the capitate bone. Literature review apropos of 3 new cases].

Authors:  P Y Milliez; H Kinh Kha; Y Allieu; J M Thomine
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.